Hanseo to invest 1 billion won for bio R&D infra.

Published: 2005-11-01 06:56:00

Updated: 2005-11-01 06:56:00

Hanseo announced on Oct. 27 that the total one billion won of investment would be made to Bio Infra and Nuvex, where Prof. Kim Cheol-woo of SNU hospital is the CEO and a majority shareholder, and these two companies already planned to merge in Dec. this year.

According to the agreement, Hanseo has an option right in negotiation for the production and distribution of the anti-cancer drug and ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.